You are here

MedImmune

Reeling from AstraZeneca's termination of pneumonia collab, Aridis lays off 20% of staff

Fierce Biotech

Mon, 04/3/23 - 10:14 am

Aridis Pharmaceuticals

monoclonal antibodies

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

Xconomy

Thu, 01/23/20 - 12:15 pm

MedImmune's top cancer researcher jumps ship to small biotech

Fierce Biotech

Wed, 10/16/19 - 12:26 pm

Inovio Pharma stock slips as AstraZeneca unit scales back agreement

Marketwatch

Wed, 05/29/19 - 10:32 am

AstraZeneca sweeps away the MedImmune name as CEO Soriot restructures R&D

Endpoints

Thu, 02/14/19 - 09:43 am

Data Confirms AstraZeneca's Imfinzi Provides Unprecedented Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer

CP Wire

Tue, 09/25/18 - 11:50 am

non-small cell lung cancer

AstraZeneca Announces Positive Results for Imfinzi in Non-Small Cell Lung Cancer

CP Wire

Fri, 05/25/18 - 09:20 am

non-small cell lung cancer

AstraZeneca's Fasenra (benralizumab) Fails Ph III Trial for COPD

CP Wire

Fri, 05/11/18 - 10:03 am

Compugen, AstraZeneca unit in cancer drug development deal

Yahoo/Reuters

Mon, 04/2/18 - 09:22 am

drug development

Needle-free flu vaccine will be back in clinics next flu season

Drug Delivery Business News

Fri, 02/23/18 - 10:11 am

needle free delivery

Nasal flu vaccine may not be recommended for use in US for years

Stat

Fri, 02/24/17 - 09:13 am

nasal flu vaccine

AstraZeneca spins out a bispecific antibody into a new cancer biotech with partner AbPro

Endpoints

Tue, 11/29/16 - 09:51 am

bispecific antibodies

MedImmune won't be impacted by AstraZeneca sale of antibiotic business to Pfizer

Bizjournals.com

Thu, 08/25/16 - 09:51 am

AstraZeneca says it is pruning staff at MedImmune, its biologics R&D center

Endpoints

Sat, 07/16/16 - 07:46 pm

What's Going On With The Nasal FluMist Vaccine?

Forbes

Mon, 06/27/16 - 09:38 am

Nasal flu vaccine is not working and should not be used this season, expert panel concludes

Stat

Thu, 06/23/16 - 09:03 am

nasal flu vaccine

TapImmune Announces Phase 2 Ovarian Cancer Trial Study with AstraZeneca/MedImmune and Sloan Kettering Cancer Institute

Yahoo

Thu, 04/21/16 - 03:14 pm

clinical trials

AstraZeneca plc (ADR) Strikes 2 Immuno-Oncology Deals; Are Its Efforts In The Right Direction?

Bidness, ETC

Fri, 08/7/15 - 10:56 am

immuno-oncology

Heptares Therapeutics

Mirati Therapeutics

AstraZeneca ties up with little Mirati on another PD-L1 combo trial

Fierce Biotech

Thu, 08/6/15 - 08:27 am

PD-1 inhibitors

Mirati Therapeutics

A MedImmune SVP dishes on nanomed, antibiotic resistance, & his advice for biopharma

BioPharma Dive

Tue, 06/23/15 - 11:20 am

antibiotic resistance

Pages